Tronieri reports receiving an investigator-initiated grant, on behalf of the University of Pennsylvania, from Novo Nordisk and receiving consulting fees from Currax Pharmaceuticals, LLC
How does it actually reduce body weight
Understanding where retatrutide stands requires understanding what makes it mechanistically distinct from its predecessors, where Phase 3 trials currently sit, what a realistic regulatory timeline looks like, and what options exist for patients who cannot or do not want to wait
Retatrutide activates three hormone receptors (GIP, GLP-1, and Glucagon), while most alternatives only target one or two
Currently, it remains in clinical development, and its off-label use carries unknown risks
Standard titration is: Week 1-2: 0.5mg Week 3-4: 1mg Week 5-6: 2mg Week 7-8: 3mg Week 9+: 4mg or stabilize where you feel satiety Track your satiety after meals